NCT01430247

Brief Summary

INTRODUCTION. Amblyopia is defined as the loss of visual acuity (VA) in one or both eyes, without any obvious structural or pathological anomalies. Amblyopic eye should be able to regain some VA if treatment is initiated before the age of seven. It is the leading cause of monocular blindness in the 20- to 70-year olds with prevalence 2-5%. Amblyopia is mainly monocular, hence children are general asymptomatic. VA testing is the only reliable method of detecting amblyopia, and the fourth year of life is considered best for vision screening programs. AIM: The purpose of the study is to reduce the preventable vision loss. The main goal of the study is to evidence the problem of amblyopia in Zagreb and to release a model for formal, government directed vision-screening program as a Croatian public health policy. HYPOTHESIS. In Croatia, the prevalence and actual effect of amblyopia and amblyogenic factors, along with treatment efficacy is impossible to quantify, since no population-based studies have been performed regarding this issue. In addition, national screening of preschool children does not exist, while the school-entry screening is prescribed by law. The object of the study is to determine the prevalence of amblyopia in a 4-4.5 year old children of The Town of Zagreb, the efficacy of screening and effectiveness of treatment on reducing amblyopia prevalence. The primary hypothesis is defined: screening of visual acuity monocularly at distance and near in 4-4.5 year old children in Zagreb is effective in detecting amblyopia. PATIENTS AND METHODS: Monocular vision of about 7000 children/ year aged 4-4.5 for whom both parents gave consent is to be tested with Lea chart at near (40cm) and distance (3m) in the kindergartens of The Town of Zagreb. The criterion for referral to complete ophthalmological examination is VA \<0.8.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2011

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 8, 2011

Completed
4 days until next milestone

Study Start

First participant enrolled

September 12, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 12, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2014

Completed
Last Updated

August 2, 2019

Status Verified

July 1, 2019

Enrollment Period

3 years

First QC Date

August 31, 2011

Last Update Submit

July 31, 2019

Conditions

Keywords

amblyopiaamblyogenic factorsscreeningpreschool childrenvisual acuityprevalence

Outcome Measures

Primary Outcomes (1)

  • prevalence of amblyopia

    proportion of children with amblyopia in a total population of children screened

    3 years

Study Arms (1)

Amblyopia screening

OTHER
Other: Amblyopia screening

Interventions

Monocular vision testing at near (40cm) and distance (3m)

Amblyopia screening

Eligibility Criteria

Age48 Months - 54 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • children in the kindergartens of The Town of Zagreb aged 4-4.5 for whom both parents gave written informed consent

You may not qualify if:

  • children younger than 4 years and children older than 4.5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Eye Clinic, University Hospital "Sveti Duh"

Zagreb, 10 000, Croatia

Location

MeSH Terms

Conditions

AmblyopiaRefractive ErrorsAnisometropiaStrabismusBlepharoptosis

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve DiseasesEyelid Diseases

Study Officials

  • Mladen Bušić

    University Eye Clinic, University Hospital "Sveti Duh", Zagreb, Croatia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Asst. prof., M.D., PhD

Study Record Dates

First Submitted

August 31, 2011

First Posted

September 8, 2011

Study Start

September 12, 2011

Primary Completion

September 12, 2014

Study Completion

September 12, 2014

Last Updated

August 2, 2019

Record last verified: 2019-07

Locations